Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes

Takanori Ishida, Takayoshi Kiba, Motohiro Takeda, Kotone Matsuyama, Satoshi Teramukai, Ryota Ishiwata, Norikazu Masuda, Yuichi Takatsuka, Shinzaburo Noguchi, Chikashi Ishioka, Masanori Fukushima, Noriaki Ohuchi

Research output: Contribution to journalArticlepeer-review

23 Citations (Scopus)

Fingerprint Dive into the research topics of 'Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds